Medical cannabis may offer little meaningful benefit for people with insomnia, according to a new review published in the ...

The designation is based on phase 2 data demonstrating dose-dependent increases in total sleep time among children and adolescents, including those with comorbid neurodevelopmental disorders.

Idorsia Pharmaceuticals (IDIA.SW) said the U.S. FDA has granted Breakthrough Therapy Designation to daridorexant for the treatment of insomnia disorder in children and adolescents aged 10 to under 18 ...

A recent study found people with insomnia had a 26% higher risk of stroke, along with increased risks of dementia, depression ...

Digital CBT for insomnia improves sleep and related symptoms in women with cancer, supporting its wider use in survivorship ...

A new report failed to find "reliable evidence" that medical cannabis can meaningfully improve people's insomnia.

A major new review challenges the growing enthusiasm for medical cannabis as an insomnia treatment, finding little reliable ...

Guidelines on pharmacotherapy for insomnia are based on the best evidence available, which is typically rated as weak by the GRADE system due to methodologic issues related to conflicts of interest ...

The FDA recognizes through this designation both the clinical evidence supporting daridorexant and the significant unmet ...

TORONTO - AUGUST 25: "Sleep Disorder" — Kevin rearranges the house to his liking after his buddies convince him that Donna makes all their decisions and has taken over the house for her own benefit.

After having insomnia for as long as I can remember, I have never slept better.

Understanding insomnia and dementia risk helps people seek treatment to protect brain health and improve daily function.